- Home
- WWD vs CTLT Comparison
WWD vs CTLT Comparison
Compare WWD & CTLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWD
- CTLT
- Stock Information
- Founded
- WWD 1870
- CTLT 2007
- Country
- WWD United States
- CTLT United States
- Employees
- WWD N/A
- CTLT N/A
- Industry
- WWD Industrial Machinery/Components
- CTLT Biotechnology: Pharmaceutical Preparations
- Sector
- WWD Energy
- CTLT Health Care
- Exchange
- WWD Nasdaq
- CTLT Nasdaq
- Market Cap
- WWD 10.1B
- CTLT 11.0B
- IPO Year
- WWD N/A
- CTLT 2014
- Fundamental
- Price
- WWD $169.55
- CTLT $59.12
- Analyst Decision
- WWD Buy
- CTLT Hold
- Analyst Count
- WWD 9
- CTLT 7
- Target Price
- WWD $178.00
- CTLT $59.83
- AVG Volume (30 Days)
- WWD 411.5K
- CTLT 1.9M
- Earning Date
- WWD 11-25-2024
- CTLT 11-05-2024
- Dividend Yield
- WWD 0.59%
- CTLT N/A
- EPS Growth
- WWD 80.33
- CTLT N/A
- EPS
- WWD 5.98
- CTLT N/A
- Revenue
- WWD $3,246,831,000.00
- CTLT $4,422,000,000.00
- Revenue This Year
- WWD $13.74
- CTLT $8.58
- Revenue Next Year
- WWD $3.14
- CTLT $7.95
- P/E Ratio
- WWD $28.33
- CTLT N/A
- Revenue Growth
- WWD 16.90
- CTLT 4.71
- 52 Week Low
- WWD $126.31
- CTLT $36.74
- 52 Week High
- WWD $188.35
- CTLT $61.20
- Technical
- Relative Strength Index (RSI)
- WWD 50.88
- CTLT 45.31
- Support Level
- WWD $173.90
- CTLT $59.34
- Resistance Level
- WWD $177.86
- CTLT $60.21
- Average True Range (ATR)
- WWD 3.87
- CTLT 0.52
- MACD
- WWD 0.46
- CTLT 0.02
- Stochastic Oscillator
- WWD 44.70
- CTLT 43.08
About WWD Woodward Inc.
Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and service reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company holds production and assembly facilities primarily in the United States, Europe, and Asia, and promotes products and services through worldwide locations.
About CTLT Catalent Inc.
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.